Listen
Reason for request
Re-assesement of the actual benefit at the request of the Committee (pursuant to Article R 163-21 of the French Social Security Code) - Extensions of indication: Diagnosis of liver lesions: diagnosis of the spread of malignant lesions, whether hepatic or not, by selective hepatic arterial injection. Embolisation with surgical glues: in association with surgical glues during vascular embolisations.
-
Clinical Benefit
| Substantial |
Interventional radiology The Committee recommends inclusion on the list of medicines approved for hospital use in the indications of interventional radiology and liver lesion diagnosis and recommendscontinued inclusion for lymphography on the list of medicinal products approved for hospital use. |
| Low |
Lymphography Diagnosis of liver lesions |
Clinical Added Value
| no clinical added value |
LIPIODOL ULTRA-FLUIDE 480 mg/ml, solution for injection does not provide any improvement in actual benefit (IAB V, non-existent) compared with existing alternatives in the diagnosis of liver lesions and vascular embolisation. |
